Andreas Halvorsen acquired 2.93 Million 4D Molecular Therapeutics shares worth $74.4 Million. That's 0.28% of their equity portfolio (64th largest holding). The investor owns 5.61% of the outstanding 4D Molecular Therapeutics stock. Andreas Halvorsen started to build up the position in 4D Molecular Therapeutics in Q4 2020 and continued to invest until Q2 2023. Since then they sold 1.85 Million shares. The investor's estimated purchase price is $104 Million, resulting in a loss of 29%.